Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
Price-to-book ratio is used to compared the company's current market price with its book value.
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
TechnicalThe key levels help you plan your entry and exit point.
-
Profit & LossTake a quick look at the revenues and expenditure sheet.
-
Balance SheetIts a statement of assets, liabilities and share capital.
-
Dividend HistoryCheck out the detailed payout data over the last three years.
-
Comparative ReturnsReveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
-
-
-
-
Moving Average
-
-
-
-
Growth in 3 years
Sales Industry Avg
PAT
PAT Industry Avg
Growth in 3 years
26.45%
Total Liabilities growth
9.50%
Reserves Change
-6.41%
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
2016 | 2014 | 2014 | |
---|---|---|---|
Sales | 59.91 | 59.91 | 59.91 |
Gross Profit | 60.14 | 60.14 | 60.14 |
Operating Profit | 6.14 | 6.14 | 6.14 |
Sales | 59.91 | 59.91 | 59.91 |
Gross Profit | 60.14 | 60.14 | 60.14 |
Operating Profit | 6.14 | 6.14 | 6.14 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
Our Research Analysis
18.2%
Target Achived
+22.8%
Buy Call with 3 month time frame
Rationale
History
15
jan 2016 |
Call initiated Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
15
jan 2016 |
Call initiated Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
15
jan 2016 |
Call initiated Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
__PERCENT__%
Target Achived
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
__Rationale__
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
__DaysLow__
__DaysHigh__
__DaysOpen__
__PreviousClose__
__Volume__
__OI__
__OIPer__
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
---|---|---|---|
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
News
Stay tuned to the latest developments and happenings in the company.
Lupin allots 51,609 equity shares under ESOP
Lupin has allotted 51,609 equity shares under ESOP on 23 October 2024. The issued and paid-up capital of the Company has been increased to Rs 91,23,89....
23 Oct 2024 15:32Lupin to table results
Lupin will hold a meeting of the Board of Directors of the Company on 7 November 2024.Powered by Capital Market - Live News
23 Oct 2024 10:43Lupin launches first generic of Pred Forte¿ Ophthalmic Suspension in the US
Lupin announced the launch of the first generic version of Pred Forte� (Prednisolone Acetate) Ophthalmic Suspension USP, 1% in the United States. Bein....
15 Oct 2024 11:17Lupin consolidated net profit rises 77.18% in the June 2024 quarter
Net profit of Lupin rose 77.18% to Rs 801.31 crore in the quarter ended June 2024 as against Rs 452.26 crore during the previous quarter ended June 20....
07 Aug 2024 07:34Lupin consolidated net profit rises 52.33% in the March 2024 quarter
Net profit of Lupin rose 52.33% to Rs 359.43 crore in the quarter ended March 2024 as against Rs 235.96 crore during the previous quarter ended March ....
07 May 2024 07:33Lupin consolidated net profit rises 299.50% in the December 2023 quarter
Net profit of Lupin rose 299.50% to Rs 613.12 crore in the quarter ended December 2023 as against Rs 153.47 crore during the previous quarter ended De....
08 Feb 2024 07:26__heading__
Published on __date__ at __time__
__description__
Corporate News
newsletter